| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 11.888.028.377 $ | 99,51 | 379.590.382 | ||||||
| ELI LILLY & CO | ELI LILLY & CO | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 1.706.053.639 $ | 14,28 | 1.422.387 | |
| JOHNSON & JOHNSON | JOHNSON & JOHNSON | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 792.013.318 $ | 6,63 | 3.118.531 | |
| UNITEDHEALTH GROUP INC | UNITEDHEALTH GROUP INC | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 715.608.043 $ | 5,99 | 1.721.743 | |
| ABBVIE INC | ABBVIE INC | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 609.298.952 $ | 5,10 | 2.421.312 | |
| MERCK & CO. INC. | MERCK & CO INC | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 478.725.722 $ | 4,01 | 3.725.492 | |
| GILEAD SCIENCES INC | GILEAD SCIENCES INC | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 336.991.230 $ | 2,82 | 2.667.336 | |
| THERMO FISHER SCIENTIFIC INC | THERMO FISHER SCIENTIFIC INC | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 301.206.559 $ | 2,52 | 600.779 | |
| VERTEX PHARMACEUTICALS INC | VERTEX PHARMACEUTICALS INC | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 272.275.099 $ | 2,28 | 548.135 | |
| BRISTOL-MYERS SQUIBB CO | BRISTOL-MYERS SQUIBB CO | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 251.849.645 $ | 2,11 | 4.370.872 | |
| ABBOTT LABORATORIES | ABBOTT LABORATORIES | EC | 002824100 | Long | Börsenkurs (Stufe 1) | 225.343.716 $ | 1,89 | 2.483.400 | |
| INTUITIVE SURGICAL INC | INTUITIVE SURGICAL INC | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 223.728.405 $ | 1,87 | 562.584 | |
| AMGEN INC | AMGEN INC | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 217.345.872 $ | 1,82 | 600.204 | |
| STRYKER CORP | STRYKER CORP | EC | 863667101 | Long | Börsenkurs (Stufe 1) | 212.882.844 $ | 1,78 | 676.162 | |
| ELEVANCE HEALTH INC | ELEVANCE HEALTH INC | EC | 036752103 | Long | Börsenkurs (Stufe 1) | 182.628.602 $ | 1,53 | 472.238 | |
| NATERA INC | NATERA INC | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 171.596.032 $ | 1,44 | 632.146 | |
| DANAHER CORP | DANAHER CORP | EC | 235851102 | Long | Börsenkurs (Stufe 1) | 170.245.500 $ | 1,43 | 893.771 | |
| GUARDANT HEALTH INC | GUARDANT HEALTH INC | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 146.367.468 $ | 1,23 | 975.588 | |
| CARDINAL HEALTH INC | CARDINAL HEALTH INC | EC | 14149Y108 | Long | Börsenkurs (Stufe 1) | 123.348.754 $ | 1,03 | 519.232 | |
| ROYALTY PHARMA PLC- CL A | ROYALTY PHARMA PLC | EC | GB00BMVP7Y09 | Long | Börsenkurs (Stufe 1) | 115.613.144 $ | 0,97 | 2.061.943 | |
| CVS HEALTH CORP | CVS HEALTH CORP | EC | 126650100 | Long | Börsenkurs (Stufe 1) | 111.947.280 $ | 0,94 | 1.082.139 | |
| TENET HEALTHCARE CORP | TENET HEALTHCARE CORP | EC | 88033G407 | Long | Börsenkurs (Stufe 1) | 111.930.338 $ | 0,94 | 598.302 | |
| KYMERA THERAPEUTICS INC | KYMERA THERAPEUTICS INC | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 106.065.966 $ | 0,89 | 924.967 | |
| PROTAGONIST THERAPEUTICS INC | PROTAGONIST THERAPEUTICS INC | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 101.564.762 $ | 0,85 | 828.559 | |
| MODERNA THERAPEUTICS INC | MODERNA INC | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 98.938.384 $ | 0,83 | 1.412.800 | |
| BRIGHTSPRING HEALTH SERVICES | BRIGHTSPRING HEALTH SERVICES INC | EC | 10950A106 | Long | Börsenkurs (Stufe 1) | 98.282.978 $ | 0,82 | 1.409.277 | |
| REVOLUTION MEDICINES INC | REVOLUTION MEDICINES INC | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 92.795.554 $ | 0,78 | 495.491 | |
| ROIVANT SCIENCES LTD | ROIVANT SCIENCES LTD | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 83.958.280 $ | 0,70 | 2.372.373 | |
| ALNYLAM PHARMACEUTICALS INC | ALNYLAM PHARMACEUTICALS INC | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 80.186.565 $ | 0,67 | 266.374 | |
| VIATRIS INC | VIATRIS INC | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 78.560.583 $ | 0,66 | 4.947.140 | |
| CHARLES RIVER LABORATORIES | CHARLES RIVER LABORATORIES INTERNATIONAL INC | EC | 159864107 | Long | Börsenkurs (Stufe 1) | 73.986.382 $ | 0,62 | 326.233 | |
| ARGENX SE - ADR | ARGENX SE | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 71.087.593 $ | 0,60 | 76.622 | |
| EDWARDS LIFESCIENCES CORP | EDWARDS LIFESCIENCES CORP | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 70.592.903 $ | 0,59 | 780.377 | |
| CENTENE CORP | CENTENE CORP | EC | 15135B101 | Long | Börsenkurs (Stufe 1) | 67.915.010 $ | 0,57 | 1.058.031 | |
| Spyre Therapeutics Inc | SPYRE THERAPEUTICS INC | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 63.197.599 $ | 0,53 | 711.845 | |
| Definium Therapeutics Inc | DEFINIUM THERAPEUTICS INC | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 60.555.439 $ | 0,51 | 1.287.318 | |
| INSMED INC | INSMED INC | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 58.459.213 $ | 0,49 | 548.295 | |
| TWIST BIOSCIENCE CORP | TWIST BIOSCIENCE CORP | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 57.098.400 $ | 0,48 | 555.000 | |
| Parabilis Medicines, Inc. Lockup Shares PP | FOG PHARMACEUTICALS SERIES C restricted Common Stock lockup | EC | Long | Modellwert (Stufe 2) | beschränkt | 56.047.821 $ | 0,47 | 2.047.783 | |
| CHUGAI PHARMACEUTICAL CO LTD | CHUGAI PHARMACEUTICAL CO LTD | EC | JP3519400000 | Long | Modellwert (Stufe 2) | 54.119.958 $ | 0,45 | 1.171.600 | |
| ASTRAZENECA PLC | ASTRAZENECA PLC | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 52.948.541 $ | 0,44 | 279.235 | |
| UNITED THERAPEUTICS CORP | UNITED THERAPEUTICS CORP | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 52.369.495 $ | 0,44 | 96.653 | |
| KRYSTAL BIOTECH INC | KRYSTAL BIOTECH INC | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 51.608.981 $ | 0,43 | 138.857 | |
| BOSTON SCIENTIFIC CORP | BOSTON SCIENTIFIC CORP | EC | 101137107 | Long | Börsenkurs (Stufe 1) | 51.073.918 $ | 0,43 | 1.196.671 | |
| MEDTRONIC PLC | MEDTRONIC PLC | EC | IE00BTN1Y115 | Long | Börsenkurs (Stufe 1) | 49.300.546 $ | 0,41 | 630.200 | |
| ERASCA INC | ERASCA INC | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 47.348.278 $ | 0,40 | 2.584.513 | |
| BILLIONTOONE INC CL A | BILLIONTOONE INC | EC | 090168105 | Long | Börsenkurs (Stufe 1) | 45.301.449 $ | 0,38 | 377.575 | |
| PRAXIS PRECISION MEDICINES I | PRAXIS PRECISION MEDICINES INC | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 44.634.203 $ | 0,37 | 133.320 | |
| MEDPACE HOLDINGS INC | MEDPACE HOLDINGS INC | EC | 58506Q109 | Long | Börsenkurs (Stufe 1) | 44.562.351 $ | 0,37 | 84.145 | |
| MONTE ROSA THERAPEUTICS INC | MONTE ROSA THERAPEUTICS INC | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 44.121.682 $ | 0,37 | 1.823.210 | |
| TANGO THERAPEUTICS INC | TANGO THERAPEUTICS INC | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 43.804.419 $ | 0,37 | 1.401.293 | |
| ORUKA THERAPEUTICS INC | ORUKA THERAPEUTICS INC | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 42.932.900 $ | 0,36 | 451.118 | |
| ASCENDIS PHARMA A/S | ASCENDIS PHARMA A/S | EC | DK0060615755 | Long | Börsenkurs (Stufe 1) | 42.641.327 $ | 0,36 | 159.873 | |
| BEONE MEDICINES LTD | BEONE MEDICINES LTD | EC | CH1391448177 | Long | Modellwert (Stufe 2) | 42.331.762 $ | 0,35 | 1.942.196 | |
| HUMANA INC | HUMANA INC | EC | 444859102 | Long | Börsenkurs (Stufe 1) | 42.224.486 $ | 0,35 | 106.300 | |
| DIANTHUS THERAPEUTICS INC | DIANTHUS THERAPEUTICS INC | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 41.794.550 $ | 0,35 | 428.750 | |
| SCHOLAR ROCK HOLDING CORP | SCHOLAR ROCK HOLDING CORP | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 40.599.900 $ | 0,34 | 738.180 | |
| KODIAK SCIENCES INC | KODIAK SCIENCES INC | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 39.494.181 $ | 0,33 | 1.013.711 | |
| AXSOME THERAPEUTICS INC | AXSOME THERAPEUTICS INC | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 37.011.672 $ | 0,31 | 151.210 | |
| SUMMIT THERAPEUTICS INC | SUMMIT THERAPEUTICS INC | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 36.880.036 $ | 0,31 | 2.531.231 | |
| NOVO-NORDISK A/S-SPONS ADR | NOVO NORDISK A/S | EC | 670100205 | Long | Börsenkurs (Stufe 1) | 36.058.982 $ | 0,30 | 752.169 | |
| REGENERON PHARMACEUTICALS | REGENERON PHARMACEUTICALS INC | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 34.706.860 $ | 0,29 | 55.661 | |
| RELAY THERAPEUTICS INC | RELAY THERAPEUTICS INC | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 34.443.164 $ | 0,29 | 1.840.896 | |
| IONIS PHARMACEUTICALS INC | IONIS PHARMACEUTICALS INC | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 34.405.755 $ | 0,29 | 433.923 | |
| CYTOKINETICS INC | CYTOKINETICS INC | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 33.687.193 $ | 0,28 | 395.436 | |
| VERA THERAPEUTICS INC | VERA THERAPEUTICS INC | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 33.654.570 $ | 0,28 | 784.306 | |
| ENLIVEN THERAPEUTICS INC | ENLIVEN THERAPEUTICS INC | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 32.858.291 $ | 0,28 | 647.454 | |
| AGILENT TECHNOLOGIES INC | AGILENT TECHNOLOGIES INC | EC | 00846U101 | Long | Börsenkurs (Stufe 1) | 32.516.784 $ | 0,27 | 244.800 | |
| MBX BIOSCIENCES INC | MBX BIOSCIENCES INC | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 32.364.257 $ | 0,27 | 586.309 | |
| CG ONCOLOGY INC | CG ONCOLOGY INC | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 31.117.982 $ | 0,26 | 437.973 | |
| NEWAMSTERDAM PHARMA CO NV | NEWAMSTERDAM PHARMA CO NV | EC | NL00150012L7 | Long | Börsenkurs (Stufe 1) | 30.924.625 $ | 0,26 | 912.500 | |
| WATERS CORP | WATERS CORP | EC | 941848103 | Long | Börsenkurs (Stufe 1) | 30.708.275 $ | 0,26 | 81.880 | |
| CRINETICS PHARMACEUTICALS IN | CRINETICS PHARMACEUTICALS INC | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 30.424.556 $ | 0,25 | 813.056 | |
| MADRIGAL PHARMACEUTICALS INC | MADRIGAL PHARMACEUTICALS INC | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 30.264.650 $ | 0,25 | 56.364 | |
| LIQUIDIA CORP | LIQUIDIA CORP | EC | 53635D202 | Long | Börsenkurs (Stufe 1) | 29.097.623 $ | 0,24 | 364.952 | |
| MIRUM PHARMACEUTICALS INC | MIRUM PHARMACEUTICALS INC | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 28.978.337 $ | 0,24 | 247.530 | |
| BEAM THERAPEUTICS INC | BEAM THERAPEUTICS INC | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 28.900.597 $ | 0,24 | 842.092 | |
| NURIX THERAPEUTICS INC | NURIX THERAPEUTICS INC | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 28.784.781 $ | 0,24 | 1.186.512 | |
| WEST PHARMACEUTICAL SERVICES | WEST PHARMACEUTICAL SERVICES INC | EC | 955306105 | Long | Börsenkurs (Stufe 1) | 27.723.775 $ | 0,23 | 77.225 | |
| IDEAYA BIOSCIENCES INC | IDEAYA BIOSCIENCES INC | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 27.094.209 $ | 0,23 | 726.971 | |
| BRIDGEBIO PHARMA INC | BRIDGEBIO PHARMA INC | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 27.054.786 $ | 0,23 | 363.249 | |
| TEVA PHARMACEUTICAL-SP ADR | TEVA PHARMACEUTICAL INDUSTRIES LTD | EC | 881624209 | Long | Börsenkurs (Stufe 1) | 26.917.660 $ | 0,23 | 794.500 | |
| RHYTHM PHARMACEUTICALS INC | RHYTHM PHARMACEUTICALS INC | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 26.831.288 $ | 0,22 | 241.658 | |
| VIRIDIAN THERAPEUTICS INC | VIRIDIAN THERAPEUTICS INC | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 26.595.021 $ | 0,22 | 1.447.742 | |
| ALKERMES PLC | ALKERMES PLC | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 26.396.601 $ | 0,22 | 503.800 | |
| TREELINE BIO SER A-1 CVT PFD STOCK PP | TREELINE BIO SER A-1 CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 25.467.020 $ | 0,21 | 2.744.291 | |
| ALIGNMENT HEALTHCARE INC | ALIGNMENT HEALTHCARE INC | EC | 01625V104 | Long | Börsenkurs (Stufe 1) | 25.381.103 $ | 0,21 | 1.065.985 | |
| Generate Biomedicines Inc Lockup Shs PP | Generate Biomedicines Inc lockup | EC | Long | Modellwert (Stufe 2) | beschränkt | 24.843.994 $ | 0,21 | 1.472.673 | |
| VAXCYTE INC | VAXCYTE INC | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 24.754.370 $ | 0,21 | 425.845 | |
| RAPPORT THERAPEUTICS INC | RAPPORT THERAPEUTICS INC | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 23.831.281 $ | 0,20 | 571.905 | |
| Aktis Oncology Inc. Lockup Shs PP | Aktis Oncology, Inc. IPO | EC | Long | Modellwert (Stufe 2) | beschränkt | 23.363.978 $ | 0,20 | 724.914 | |
| IMMUNOME INC | IMMUNOME INC | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 23.156.729 $ | 0,19 | 1.092.814 | |
| STRUCTURE THERAPEUTICS INC ADR | STRUCTURE THERAPEUTICS INC | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 22.509.574 $ | 0,19 | 419.407 | |
| PALVELLA THERAPEUTICS INC | PALVELLA THERAPEUTICS INC | EC | 697947109 | Long | Börsenkurs (Stufe 1) | 22.039.700 $ | 0,18 | 144.220 | |
| TREELINE BIO SER A CVT PFD STOCK PP | TREELINE BIO SER A CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 21.994.992 $ | 0,18 | 2.370.150 | |
| Climb Bio Inc | CLIMB BIO INC | EC | 28658R106 | Long | Börsenkurs (Stufe 1) | 21.333.088 $ | 0,18 | 1.635.973 | |
| ICON PLC | ICON PLC | EC | IE0005711209 | Long | Börsenkurs (Stufe 1) | 20.879.942 $ | 0,17 | 120.200 | |
| IMMUNOCORE HOLDINGS PLC-ADR | IMMUNOCORE HOLDINGS PLC | EC | 45258D105 | Long | Börsenkurs (Stufe 1) | 20.487.259 $ | 0,17 | 645.268 | |
| KAILERA THERAPEUTICS INC | KAILERA THERAPEUTICS INC | EC | 482931102 | Long | Börsenkurs (Stufe 1) | 19.921.354 $ | 0,17 | 904.283 | |
| CELLDEX THERAPEUTICS INC | CELLDEX THERAPEUTICS INC | EC | 15117B202 | Long | Börsenkurs (Stufe 1) | 18.407.489 $ | 0,15 | 494.692 | |
| BICARA THERAPEUTICS INC | BICARA THERAPEUTICS INC | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 17.547.206 $ | 0,15 | 591.014 | |
| CENCORA INC | CENCORA INC | EC | 03073E105 | Long | Börsenkurs (Stufe 1) | 17.306.208 $ | 0,14 | 61.157 | |
| Avalyn Pharma Inc Lockup Shares PP | Avalyn Pharma, Inc. restricted Common Stock lockup | EC | Long | Modellwert (Stufe 2) | beschränkt | 17.284.053 $ | 0,14 | 525.032 | |
| SONOVA HOLDING AG-REG | SONOVA HOLDING AG | EC | CH0012549785 | Long | Modellwert (Stufe 2) | 17.171.291 $ | 0,14 | 72.348 | |
| CELLANOME SERIES A CVT PFD STOCK PP | CELLANOME SERIES A CVT PFD STOCK PP | EP | TC13MXKE8 | Long | Schätzwert (Stufe 3) | beschränkt | 16.923.856 $ | 0,14 | 1.993.387 |
| ALUMIS INC | ALUMIS INC | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 16.741.133 $ | 0,14 | 594.923 | |
| APOGEE THERAPEUTICS INC | APOGEE THERAPEUTICS INC | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 16.736.988 $ | 0,14 | 126.098 | |
| ORIC PHARMACEUTICALS INC | ORIC PHARMACEUTICALS INC | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 16.603.711 $ | 0,14 | 1.533.122 | |
| INSITRO SER B CVT PFD PP | INSITRO SER B CVT PFD PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 16.161.650 $ | 0,14 | 883.580 | |
| VEEVA SYSTEMS INC CL A | VEEVA SYSTEMS INC | EC | 922475108 | Long | Börsenkurs (Stufe 1) | 16.149.770 $ | 0,14 | 91.000 | |
| Seaport Therapeutics Inc Lockup Shares PP | Seaport Therapeutics, Inc. restricted Common Stock lockup | EC | Long | Modellwert (Stufe 2) | beschränkt | 16.059.594 $ | 0,13 | 739.392 | |
| MOONLAKE IMMUNOTHERAPEUTICS | MOONLAKE IMMUNOTHERAPEUTICS | EC | 61559X104 | Long | Börsenkurs (Stufe 1) | 15.421.642 $ | 0,13 | 792.072 | |
| ENCOMPASS HEALTH CORP | ENCOMPASS HEALTH CORP | EC | 29261A100 | Long | Börsenkurs (Stufe 1) | 15.299.469 $ | 0,13 | 151.360 | |
| Genesis Molecular AI Ser B CVT PFD PP | GENESIS THERA SEV B CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 14.835.334 $ | 0,12 | 1.987.585 | |
| OCULAR THERAPEUTIX INC | OCULAR THERAPEUTIX INC | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 14.066.816 $ | 0,12 | 1.432.466 | |
| BIOHAVEN LTD | BIOHAVEN LTD | EC | VGG1110E1079 | Long | Börsenkurs (Stufe 1) | 14.003.776 $ | 0,12 | 941.114 | |
| ABIVAX SA-ADR | ABIVAX SA | EC | 00370M103 | Long | Börsenkurs (Stufe 1) | 13.866.236 $ | 0,12 | 104.054 | |
| COGENT BIOSCIENCES INC | COGENT BIOSCIENCES INC | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 13.819.035 $ | 0,12 | 357.081 | |
| Kailera Therapeutics Inc Lockup Shares PP | Kailera Therapeutics, Inc PP estricted lockup | EC | Long | Modellwert (Stufe 2) | beschränkt | 13.806.267 $ | 0,12 | 626.703 | |
| SHATTUCK LABS INC | SHATTUCK LABS INC | EC | 82024L103 | Long | Börsenkurs (Stufe 1) | 13.783.527 $ | 0,12 | 1.986.099 | |
| STOKE THERAPEUTICS INC | STOKE THERAPEUTICS INC | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 13.707.520 $ | 0,11 | 418.934 | |
| IMMIX BIOPHARMA INC | IMMIX BIOPHARMA INC | EC | 45258H106 | Long | Börsenkurs (Stufe 1) | 13.673.699 $ | 0,11 | 1.326.256 | |
| INCYTE CORP | INCYTE CORP | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 13.585.062 $ | 0,11 | 119.840 | |
| ARSENAL BIOSCIENCES SER C CVT PFD PP | ARSENAL BIOSCIENCES SER C CVT PFD PP | EP | TC5YX3EI8 | Long | Schätzwert (Stufe 3) | beschränkt | 13.459.241 $ | 0,11 | 724.394 |
| ARROWHEAD PHARMACEUTICALS INC | ARROWHEAD PHARMACEUTICALS INC | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 13.446.705 $ | 0,11 | 164.970 | |
| DELFI DIAGNOSTICS SR A CVT PFD STOCK PP | DELFI DIAGNOSTICS SR A CVT PFD STOCK PP | EP | TC0LOSSE0 | Long | Schätzwert (Stufe 3) | beschränkt | 13.399.054 $ | 0,11 | 3.426.868 |
| PARABILIS MEDICINES INC | PARABILIS MEDICINES INC | EC | 698955101 | Long | Börsenkurs (Stufe 1) | 13.320.131 $ | 0,11 | 486.669 | |
| AVALYN PHARMA INC | AVALYN PHARMA INC | EC | 05348Y105 | Long | Börsenkurs (Stufe 1) | 13.038.591 $ | 0,11 | 396.069 | |
| IMMUNOCORE HOLDINGS CB 2.50% 2/30 | IMMUNOCORE HOLDINGS PLC | DBT | 45258DAB1 | Long | Modellwert (Stufe 2) | 12.933.251 $ | 0,11 | 14.261.000 | |
| SIONNA THERAPEUTICS INC | SIONNA THERAPEUTICS INC | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 12.653.416 $ | 0,11 | 287.643 | |
| Mirum Pharma 9 month Lockup Shs PP | MIRUM PHARMA 9 MONTH LOCKUP SHS PP | EC | Long | Modellwert (Stufe 2) | beschränkt | 12.499.956 $ | 0,10 | 112.393 | |
| Mirum Pharma 6 month Lockup Shs PP | MIRUM PHARMA 6 MONTH LOCKUP SHS PP | EC | Long | Modellwert (Stufe 2) | beschränkt | 12.499.956 $ | 0,10 | 112.393 | |
| BELITE BIO INC - ADR | BELITE BIO INC | EC | 07782B104 | Long | Börsenkurs (Stufe 1) | 12.389.941 $ | 0,10 | 80.462 | |
| ENDEAVOR BIO SERIES B CVT PFD STOCK PP | END EAVOR BIO SERIES B CVT PFD STOCK PP | EP | TC0KH48I6 | Long | Schätzwert (Stufe 3) | beschränkt | 12.186.217 $ | 0,10 | 1.867.734 |
| CLEAR LABS SERIES C CVT PFD PP | CLEAR LABS SERIES C CVT PFD PP | EP | TC385IBS6 | Long | Schätzwert (Stufe 3) | beschränkt | 12.119.800 $ | 0,10 | 3.830.773 |
| BIONTECH SE-ADR | BIONTECH SE | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 11.780.130 $ | 0,10 | 126.600 | |
| INSITRO SER C CVT PFD PP | INSITRO SER C CVT PFD PP | EP | TC3HHHWL7 | Long | Schätzwert (Stufe 3) | beschränkt | 10.762.154 $ | 0,09 | 588.382 |
| AKTIS ONCOLOGY INC | AKTIS ONCOLOGY INC | EC | 01021M104 | Long | Börsenkurs (Stufe 1) | 10.756.601 $ | 0,09 | 333.745 | |
| GALVANIZE THERA SER C-2 NV CVT PFD PP | Galvanize Therapeutics Series C-2 CVT PFD | EP | Long | Schätzwert (Stufe 3) | beschränkt | 10.701.000 $ | 0,09 | 26.100.000 | |
| Cullinan Therapeutics Inc | CULLINAN THERAPEUTICS INC | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 10.631.053 $ | 0,09 | 583.803 | |
| QUEST DIAGNOSTICS INC | QUEST DIAGNOSTICS INC | EC | 74834L100 | Long | Börsenkurs (Stufe 1) | 10.618.695 $ | 0,09 | 50.100 | |
| KARTOS THERAPEUTICS SR C CVT PFD STK PP | KARTOS THERAPEUTICS SR C CVT PFD STK PP | EP | TC1HQTAC7 | Long | Schätzwert (Stufe 3) | beschränkt | 10.592.823 $ | 0,09 | 1.873.841 |
| NATIONAL RESILIENCE SR B CVT PFD STK PP | NATIONAL RESILIENCE SER B CVT PFD STOCK | EP | Long | Schätzwert (Stufe 3) | beschränkt | 10.409.748 $ | 0,09 | 1.204.832 | |
| CLEERLY SER C CVT PFD STK PP | CLEERLY SER C CVT PFD STK PP | EP | TC1A1CZJ4 | Long | Schätzwert (Stufe 3) | beschränkt | 10.284.809 $ | 0,09 | 586.029 |
| DENALI THERAPEUTICS INC | DENALI THERAPEUTICS INC | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 10.235.145 $ | 0,09 | 397.945 | |
| Kardium Inc Ser D-6 CVT Pfd Stock PP | KARDIUM SERIES D6 CVT PFD STOCK PP | EP | TC0GUUWU8 | Long | Schätzwert (Stufe 3) | beschränkt | 10.193.893 $ | 0,09 | 12.320.393 |
| THIRD ARC BIO SER A CVT PFD PP | THIRD ARC BIO SER A CVT PFD PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 10.123.172 $ | 0,08 | 4.810.936 | |
| TARSUS PHARMACEUTICALS INC | TARSUS PHARMACEUTICALS INC | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 9.950.562 $ | 0,08 | 158.096 | |
| PHARVARIS NV | PHARVARIS NV | EC | NL00150005Y4 | Long | Börsenkurs (Stufe 1) | 9.745.474 $ | 0,08 | 281.824 | |
| TYRA BIOSCIENCES INC | TYRA BIOSCIENCES INC | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 9.699.188 $ | 0,08 | 303.669 | |
| DISC MEDICINE INC | DISC MEDICINE INC | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 9.680.737 $ | 0,08 | 132.359 | |
| ELEMENT BIOSCIENCES SER C CVT PFD STOCK PP | ELEMENT BIOSCIENCES SER C CVT PFD STOCK | EP | Long | Schätzwert (Stufe 3) | beschränkt | 9.507.836 $ | 0,08 | 861.217 | |
| CORVUS PHARMACEUTICALS INC | CORVUS PHARMACEUTICALS INC | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 9.208.882 $ | 0,08 | 616.391 | |
| AVALO THERAPEUTICS INC | AVALO THERAPEUTICS INC | EC | 05338F306 | Long | Börsenkurs (Stufe 1) | 8.719.271 $ | 0,07 | 471.822 | |
| NANOBIOTIX | NANOBIOTIX SA | EC | FR0011341205 | Long | Modellwert (Stufe 2) | 8.441.473 $ | 0,07 | 229.242 | |
| IQVIA HOLDINGS INC | IQVIA HOLDINGS INC | EC | 46266C105 | Long | Börsenkurs (Stufe 1) | 8.106.159 $ | 0,07 | 41.953 | |
| Kardium Inc Series D-7 CVT PFD Stock PP | Kardium, Inc. Series D-7 CVT Pfd Stock | EP | Long | Schätzwert (Stufe 3) | beschränkt | 7.799.613 $ | 0,07 | 12.050.573 | |
| NCHROMA BIO SER I CVT PFD STOCK PP | CHROMA MEDICINE SER I CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 7.683.800 $ | 0,06 | 7.683.800 | |
| KYVERNA THERAPEUTICS INC | KYVERNA THERAPEUTICS INC | EC | 501976104 | Long | Börsenkurs (Stufe 1) | 7.634.070 $ | 0,06 | 856.798 | |
| ATRIUM THERAPEUTICS INC | ATRIUM THERAPEUTICS INC | EC | 04965N104 | Long | Börsenkurs (Stufe 1) | 7.618.457 $ | 0,06 | 566.428 | |
| HEMAB THERAPEUTICS HOLDINGS | HEMAB THERAPEUTICS HOLDINGS INC | EC | 423494103 | Long | Börsenkurs (Stufe 1) | 7.597.233 $ | 0,06 | 206.840 | |
| OLEMA PHARMACEUTICALS INC | OLEMA PHARMACEUTICALS INC | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 7.301.049 $ | 0,06 | 583.617 | |
| KARDIUM INC SER D-5 CVT PFD STOCK PP | KARDIUM INC SER D-5 CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 7.249.147 $ | 0,06 | 8.849.057 | |
| DELFI DIAGNOSTICS SR B CVT PFD STOCK PP | DELFI DIAGNOSTICS SR B CVT PFD STOCK PP | EP | TC7ZV25B2 | Long | Schätzwert (Stufe 3) | beschränkt | 7.245.770 $ | 0,06 | 1.853.138 |
| ALLOGENE THERAPEUTICS INC | ALLOGENE THERAPEUTICS INC | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 7.163.730 $ | 0,06 | 3.444.101 | |
| OBSIDIAN THERAPEUTIC SR C CVT PFD STK PP | OBSIDIAN THERAPEUTICS SR C CVT PFD STK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 7.064.647 $ | 0,06 | 4.647.794 | |
| WAVE LIFE SCIENCES LTD | WAVE LIFE SCIENCES LTD | EC | SG9999014716 | Long | Börsenkurs (Stufe 1) | 6.904.796 $ | 0,06 | 1.188.433 | |
| SEAPORT THERAPEUTICS INC | SEAPORT THERAPEUTICS INC | EC | 81221K108 | Long | Börsenkurs (Stufe 1) | 6.501.209 $ | 0,05 | 299.319 | |
| TENAX THERAPEUTICS INC | TENAX THERAPEUTICS INC | EC | 88032L605 | Long | Börsenkurs (Stufe 1) | 6.488.951 $ | 0,05 | 445.976 | |
| ADAPTIVE BIOTECHNOLOGIES | ADAPTIVE BIOTECHNOLOGIES CORP | EC | 00650F109 | Long | Börsenkurs (Stufe 1) | 6.276.013 $ | 0,05 | 292.588 | |
| SCRIBE THERA SER B CVT PFD STOCK PP | SCRIBE THERA SER B CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 6.219.254 $ | 0,05 | 1.027.755 | |
| Genesis Molecular AI Ser A CVT PFD PP | GENESIS THERA SER A CVT PFD STOCK PP | EP | TC08XH789 | Long | Schätzwert (Stufe 3) | beschränkt | 6.190.731 $ | 0,05 | 829.412 |
| ALTO NEUROSCIENCE INC | ALTO NEUROSCIENCE INC | EC | 02157Q109 | Long | Börsenkurs (Stufe 1) | 6.018.424 $ | 0,05 | 228.057 | |
| IOVANCE BIOTHERAPEUTICS INC | IOVANCE BIOTHERAPEUTICS INC | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 5.989.743 $ | 0,05 | 1.439.842 | |
| NATIONAL RESILIENCE SR C CVT PFD STK PP | NATIONAL RESILIENCE SER C CVT PFD STOCK | EP | Long | Schätzwert (Stufe 3) | beschränkt | 5.672.903 $ | 0,05 | 426.855 | |
| CABALETTA BIO INC | CABALETTA BIO INC | EC | 12674W109 | Long | Börsenkurs (Stufe 1) | 5.584.512 $ | 0,05 | 1.795.663 | |
| PROCEPT BIOROBOTICS CORP | PROCEPT BIOROBOTICS CORP | EC | 74276L105 | Long | Börsenkurs (Stufe 1) | 5.559.444 $ | 0,05 | 246.211 | |
| SPYGLASS PHARMA INC | SPYGLASS PHARMA INC | EC | 85220G109 | Long | Börsenkurs (Stufe 1) | 5.502.583 $ | 0,05 | 247.196 | |
| XENCOR INC | XENCOR INC | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 5.479.490 $ | 0,05 | 340.341 | |
| Galvanize Therapeutics Ser C CVT PFD PP | GALVANIZE THERAPEUTICS SER C CVT PFD PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 5.440.893 $ | 0,05 | 13.270.470 | |
| GENERATE BIOMEDICINES INC | GENERATE BIOMEDICINES INC | EC | 370920100 | Long | Börsenkurs (Stufe 1) | 5.313.443 $ | 0,04 | 314.964 | |
| CELCUITY INC | CELCUITY INC | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 5.157.766 $ | 0,04 | 49.300 | |
| COLOR HEALTH SR D CVT PFD STOCK PP | COLOR HEALTH SER D CVT PFD STOCK PP | EP | TC1HL9RU8 | Long | Schätzwert (Stufe 3) | beschränkt | 5.077.366 $ | 0,04 | 296.922 |
| COLOR HEALTH SR D-1 CVT PFD STOCK PP | COLOR HEALTH SERIES D-1 CVT PFD STOCK PP | EP | TC3KSMZE0 | Long | Schätzwert (Stufe 3) | beschränkt | 5.023.069 $ | 0,04 | 438.696 |
| Eikon Therapeutics, Inc Lockup Shs PP | Eikon Therapeutics, Inc. IPO lockup | EC | Long | Modellwert (Stufe 2) | beschränkt | 4.847.318 $ | 0,04 | 371.442 | |
| EVOMMUNE INC | EVOMMUNE INC | EC | 30054Y107 | Long | Börsenkurs (Stufe 1) | 4.606.753 $ | 0,04 | 346.633 | |
| EIKON THERAPEUTICS INC | EIKON THERAPEUTICS INC | EC | 282564103 | Long | Börsenkurs (Stufe 1) | 4.555.729 $ | 0,04 | 349.098 | |
| FREENOME HOLDINGS SER B CVT PFD PP | FREENOME HOLDINGS SER B CVT PFD PP | EP | Long | Modellwert (Stufe 2) | beschränkt | 4.512.831 $ | 0,04 | 1.558.570 | |
| INSPIRE MEDICAL SYSTEMS INC | INSPIRE MEDICAL SYSTEMS INC | EC | 457730109 | Long | Börsenkurs (Stufe 1) | 4.405.148 $ | 0,04 | 98.748 | |
| Kardium Inc Series D-8 CVT PFD Stock PP | KARDIUM INC SERIES D-8 CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 4.392.791 $ | 0,04 | 6.786.958 | |
| Deepsight Tech Inc SER C CVT PFD PP | Deepsight Tech Inc SER C CVT PFD PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 4.378.728 $ | 0,04 | 342.294 | |
| SPAC PCSC Freenome PIPE COMMIT PP | SPAC PCSC FREENOME PIPE COMMIT PP | EC | Long | Modellwert (Stufe 2) | beschränkt | 4.290.639 $ | 0,04 | 438.178 | |
| MANUS BIO INC SERIES ONE-6 CVT PFD PP | Manus Bio, Inc Series One-6 | EC | Long | Schätzwert (Stufe 3) | beschränkt | 3.987.319 $ | 0,03 | 1.223.104 | |
| SENSORION SA | SENSORION SA | EC | FR0012596468 | Long | Modellwert (Stufe 2) | 3.709.700 $ | 0,03 | 13.728.347 | |
| Odyssey Therapeutics Inc Lockup Shares PP | Odyssey Therapeutics, Inc Common IPO | EC | Long | Modellwert (Stufe 2) | beschränkt | 3.564.049 $ | 0,03 | 190.489 | |
| XENON PHARMACEUTICALS INC | XENON PHARMACEUTICALS INC | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 3.500.880 $ | 0,03 | 58.000 | |
| TESSERA THERAPEUTICS SER C' CVT PFD PP | Tessera Therapeutics, Inc. Series C | EC | Long | Schätzwert (Stufe 3) | beschränkt | 3.492.221 $ | 0,03 | 674.174 | |
| AGIOS PHARMACEUTICALS INC | AGIOS PHARMACEUTICALS INC | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 3.478.209 $ | 0,03 | 93.727 | |
| ODYSSEY THERAPEUTICS INC | ODYSSEY THERAPEUTICS INC | EC | 67613T104 | Long | Börsenkurs (Stufe 1) | 3.415.454 $ | 0,03 | 182.547 | |
| CRESCENT BIOPHARMA INC | CRESCENT BIOPHARMA INC | EC | KYG2545C1042 | Long | Börsenkurs (Stufe 1) | 3.382.560 $ | 0,03 | 187.920 | |
| BIOMARIN PHARMACEUTICAL | BIOMARIN PHARMACEUTICAL INC | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 3.358.814 $ | 0,03 | 58.700 | |
| IMMATICS NV | IMMATICS NV | EC | N44445109 | Long | Börsenkurs (Stufe 1) | 3.255.417 $ | 0,03 | 321.364 | |
| ENDEAVOR BIO SER C CVT PFD PP | ENDEAVOR BIO SER C CVT PFD PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 3.195.495 $ | 0,03 | 489.761 | |
| GALVANIZE THERA SER C-1 CVT PFD PP | Galvanize Therapeutics Series C-1 CVT PFD | EP | Long | Schätzwert (Stufe 3) | beschränkt | 3.165.891 $ | 0,03 | 7.721.685 | |
| GE HEALTHCARE TECHNOLOGIES INC | GE HEALTHCARE TECHNOLOGIES INC | EC | 36266G107 | Long | Börsenkurs (Stufe 1) | 2.989.267 $ | 0,03 | 46.700 | |
| Kartos Therapeutics SR D CVT PFD STK PP | KARTOS THERAPEUTICS SR D CVT PFD STK PP | EP | TC82Z0AE2 | Long | Schätzwert (Stufe 3) | beschränkt | 2.904.082 $ | 0,02 | 513.724 |
| Mirum Pharma Indemnity Holdback Shs PP | Mirum Pharma Indemnity Holdback Shs PP | EC | Long | Modellwert (Stufe 2) | beschränkt | 2.794.426 $ | 0,02 | 25.126 | |
| Treeline Bio SER A-2 CVT PFD PP | TREELINE BIO SER A-2 NV CVT PFD PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 2.778.877 $ | 0,02 | 299.448 | |
| FREENOME HOLDINGS SER C CVT PFD PP | FREENOME HOLDINGS SER C CVT PFD PP | EP | TC87S2BF1 | Long | Modellwert (Stufe 2) | beschränkt | 2.687.688 $ | 0,02 | 928.231 |
| BICYCLE THERAPEUTICS PLC-ADR | BICYCLE THERAPEUTICS PLC | EC | 088786108 | Long | Börsenkurs (Stufe 1) | 2.664.505 $ | 0,02 | 628.421 | |
| DYNE THERAPEUTICS INC | DYNE THERAPEUTICS INC | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 2.600.791 $ | 0,02 | 117.100 | |
| ELEMENT BIOSCIENCES SER D CVT PFD PP | ELEMENT BIOSCIENCES SER D CVT PFD PP | EP | TC3OATBR3 | Long | Schätzwert (Stufe 3) | beschränkt | 2.512.491 $ | 0,02 | 281.354 |
| ELEMENT BIOSCIENCES SER D-1 CVT PFD PP | ELEMENT BIOSCIENCES SER D-1 CVT PFD PP | EP | TC141T8S1 | Long | Schätzwert (Stufe 3) | beschränkt | 2.512.491 $ | 0,02 | 281.354 |
| ARBOR BIO SERIES B CVT PFD STOCK PP | ARBOR BIO SERIES B CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 2.408.071 $ | 0,02 | 532.759 | |
| PAX LABS CLASS A COMMON PP | PAX LABS CLASS A COMMON PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 2.267.457 $ | 0,02 | 8.397.988 | |
| ENTRADA THERAPEUTICS INC | ENTRADA THERAPEUTICS INC | EC | 29384C108 | Long | Börsenkurs (Stufe 1) | 2.178.420 $ | 0,02 | 295.981 | |
| LUMICKS TECH SER D CVT PFD STOCK PP | LUMICKS TECH SER D CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 2.165.790 $ | 0,02 | 4.954 | |
| TESSERA THERAPEUTICS SER D CVT PFD PP | TESSERA THERAPEUTICS SER D CVT PFD PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 1.978.703 $ | 0,02 | 381.989 | |
| IMMUNEERING CORP - CLASS A | IMMUNEERING CORP | EC | 45254E107 | Long | Börsenkurs (Stufe 1) | 1.934.583 $ | 0,02 | 387.692 | |
| REVOLUTION MEDICINES INC WTS 12/26 | REVOLUTION MEDICINES INC | EC | 76155X118 | Long | Börsenkurs (Stufe 1) | 1.865.947 $ | 0,02 | 198.505 | |
| DNA SCRIPT SERIES C CVT PFD STOCK PP | DNA SCRIPT SERIES C CVT PFD STOCK PP | EP | TC3XW4UW2 | Long | Schätzwert (Stufe 3) | beschränkt | 1.807.729 $ | 0,02 | 25.201 |
| CARIS LIFE SCIENCES INC | CARIS LIFE SCIENCES INC | EC | 142152107 | Long | Börsenkurs (Stufe 1) | 1.770.720 $ | 0,01 | 99.367 | |
| Delfi Diagnostics CVT Prom Note PP | DELFI DIAGNOSTICS CVT PROM NOTE PP | DBT | Long | Schätzwert (Stufe 3) | beschränkt | 1.732.158 $ | 0,01 | 1.732.158 | |
| COLOR HEALTH SERIES E CVT PFD STOCK PP | COLOR HEALTH SERIES E CVT PFD STOCK PP | EP | TC4SC4HB5 | Long | Schätzwert (Stufe 3) | beschränkt | 1.706.800 $ | 0,01 | 44.149 |
| BridgeBio Oncology Therapeutics Inc | BRIDGEBIO ONCOLOGY THERAPEUTICS INC | EC | 107924102 | Long | Börsenkurs (Stufe 1) | 1.695.541 $ | 0,01 | 222.512 | |
| FREENOME HOLDINGS SER D CVT PFD PP | FREENOME HOLDINGS SER D CVT PFD PP | EP | Long | Modellwert (Stufe 2) | beschränkt | 1.524.489 $ | 0,01 | 526.504 | |
| MAPLIGHT THERAPEUTICS INC | MAPLIGHT THERAPEUTICS INC | EC | 56565P103 | Long | Börsenkurs (Stufe 1) | 1.518.075 $ | 0,01 | 42.357 | |
| ARBOR BIO SERIES C CVT PFD STOCK PP | ARBOR BIO SERIES C CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 1.455.874 $ | 0,01 | 322.096 | |
| Verily Health, Inc. CL B Common Stock PP | VERILY LIFE SCIENCES LLC SER B UNITS PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 1.265.989 $ | 0,01 | 113.564 | |
| Saluda Medical Inc Lockup Shs CDI PP | SALUDA MEDICAL INC PP restricted cdi | EC | Long | Modellwert (Stufe 2) | beschränkt | 1.183.230 $ | 0,01 | 3.715.230 | |
| CLEAR LABS SER D CVT PFD STOCK PP | CLEAR LABS SER D CVT PFD STOCK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 1.183.027 $ | 0,01 | 379.601 | |
| Mirum Pharma Escrow Indemnity PP | Mirum Pharma Escrow Indemnity PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 1.133.167 $ | 0,01 | 1.192.808 | |
| TECTONIC THERAPEUTIC INC | TECTONIC THERAPEUTIC INC | EC | 878972108 | Long | Börsenkurs (Stufe 1) | 1.052.975 $ | 0,01 | 30.632 | |
| Cabaletta Bio Common WTS 09/26 PP | CABALETTA BIO COMMON WTS 09/26 PP | EC | Long | Modellwert (Stufe 2) | beschränkt | 1.033.557 $ | 0,01 | 1.694.355 | |
| HONOR TECHNOLOGY SER D CVT PFD PP | HONOR TECHNOLOGY SER D CVT PFD PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 939.282 $ | 0,01 | 3.130.941 | |
| CAPSULE CORP SERIES E CVT PFD STOCK PP | CAPSULE CORP SERIES E CVT PFD STOCK PP | EP | TC0YJ3TD4 | Long | Schätzwert (Stufe 3) | beschränkt | 915.723 $ | 0,01 | 906.656 |
| CAPSULE CORP SERIES 1-D CVT PFD STOCK | CAPSULE CORP SERIES 1-D CVT PFD STOCK | EP | Long | Schätzwert (Stufe 3) | beschränkt | 861.745 $ | 0,01 | 853.213 | |
| SAIL BIOMEDICINES SER B CVT PFD STOCK PP | LARONDE SERIES B CVT PFD STOCK PP | EP | TC14DLDG5 | Long | Schätzwert (Stufe 3) | beschränkt | 760.427 $ | 0,01 | 1.169.887 |
| Kartos Therapeutics CVT Prom Note 03/27 PP | KARTOS THERAPEUTICS CVT PROM NOTE PP | DBT | TC9IB1JR2 | Long | Schätzwert (Stufe 3) | beschränkt | 741.016 $ | 0,01 | 741.016 |
| AURA BIOSCIENCES INC | AURA BIOSCIENCES INC | EC | 05153U107 | Long | Börsenkurs (Stufe 1) | 696.822 $ | 0,01 | 98.144 | |
| PROFOUNDBIO ESCROW FUND PAYMENT PP | PROFOUNBIO ESCROW FUND PAYMENT | EP | Long | Schätzwert (Stufe 3) | beschränkt | 669.262 $ | 0,01 | 704.486 | |
| Reflexion Med CVT Note issued 072525 PP | REFLEXION MEDICAL CVT PROM NOTE PP | DBT | Long | Schätzwert (Stufe 3) | beschränkt | 656.772 $ | 0,01 | 239.698 | |
| Reflexion Med CVT Note issued 081325 PP | REFLEXION MED CVT PROM NOTE 081325 PP | DBT | Long | Schätzwert (Stufe 3) | beschränkt | 651.979 $ | 0,01 | 239.698 | |
| Reflexion Med CVT Note issued 082725 PP | REFLEXION MED CVT NOTE ISSUED 082725 PP | DBT | Long | Schätzwert (Stufe 3) | beschränkt | 647.185 $ | 0,01 | 239.698 | |
| HONOR TECHNOLOGY SER E CVT PFD STOCK PP | HONOR TECHNOLOGY SER E CVT PFD STOCK PP | EP | TC2V4FT13 | Long | Schätzwert (Stufe 3) | beschränkt | 628.742 $ | 0,01 | 2.095.807 |
| FREENOME HOLDINGS SER F CVT PFD PP | FREENOME HOLDINGS SER F CVT PFD PP | EP | TC17ZDYA2 | Long | Modellwert (Stufe 2) | beschränkt | 517.445 $ | 0,00 | 178.707 |
| Treeline Bio Common WTS 8/35 PP | TREELINE BIO COMMON WTS 8.35 PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 416.830 $ | 0,00 | 44.917 | |
| Kartos Therapeutics CVT Note 05/27 PP | KARTOS THERAPEUTICS CVT NOTE 05.27 PP | DBT | Long | Schätzwert (Stufe 3) | beschränkt | 185.253 $ | 0,00 | 185.253 | |
| PROGNOMIQ INC CL A Common PP | PROGNOMIQ INC PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 90.997 $ | 0,00 | 606.647 | |
| Mirum Pharma Escrow Expense Fund PP | Mirum Pharma Escrow Expense Fund PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 45.692 $ | 0,00 | 48.097 | |
| Mirum Pharma Escrow Working Capital PP | Mirum Pharma Escrow Working Capital PP | EC | Long | Schätzwert (Stufe 3) | 45.692 $ | 0,00 | 48.097 | ||
| Chromacode INC SER AA CVT PFD STK PP | CHROMACODE INC SER AA CVT PFD STK PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 44.582 $ | 0,00 | 36.845 | |
| AFFINIVAX EXPENSE FUND PP | AFFINIVAX EXPENSE FUND PP | EC | TC929D1E2 | Long | Schätzwert (Stufe 3) | beschränkt | 11.563 $ | 0,00 | 12.445 |
| REFLEXION MEDICAL INC CVT PFD SR C-X PP | REFLEXION MEDICAL INC CVT PFD SR C PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 3.260 $ | 0,00 | 2.507.885 | |
| REFLEXION MEDICAL INC CVT PFD SR E-X PP | REFLEXION MEDICAL INC SR E CVT PFD PP | EP | TC9L8ZXJ6 | Long | Schätzwert (Stufe 3) | beschränkt | 2.600 $ | 0,00 | 1.857.286 |
| REFLEXION MEDICAL SER F CVT PFD STOCK PP | REFLEXION MEDICAL INC PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 1.794 $ | 0,00 | 1.794.104 | |
| REFLEXION MEDICAL INC CVT PFD SR D-X PP | REFLEXION MEDICAL INC CVT | EP | TC70GKL85 | Long | Schätzwert (Stufe 3) | beschränkt | 1.460 $ | 0,00 | 1.123.437 |
| CHROMACODE INC PP | CHROMACODE INC PP | EC | TC43UPY99 | Long | Schätzwert (Stufe 3) | beschränkt | 757 $ | 0,00 | 626 |
| GENEDX HOLDINGS CORP WTS 7/26 | GENEDX HOLDINGS CORP | EC | 81663L119 | Long | Börsenkurs (Stufe 1) | 600 $ | 0,00 | 206.747 | |
| Blue Marlin Therapeutics Common Stock PP | BLUE MARLIN THERAPEUTICS COMMON STOCK PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 180 $ | 0,00 | 1.803 | |
| PROFOUNDBIO EXPENSE FUND PAYMENT PP | PROFOUNDBIO EXPENSE FUND PYMT | EP | Long | Schätzwert (Stufe 3) | beschränkt | 117 $ | 0,00 | 2.348 | |
| SOMALOGIC INC WTS 8/26 | SOMALOGIC INC | EC | 83444K113 | Long | Modellwert (Stufe 2) | 0 $ | 0,00 | 90.179 | |
| GYROSCOPE THERAPEUTICS MLSTNE PYMT 3 PP | GYROSCOPE THERAPEUTICS MILESTONE PAYMENT 3 PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 3.788.007 | |
| GINKGO BIOWORKS HLDS ERN OUT SHS 600 PP | Ginkgo Bioworks Holdings Earn Out Shares $15.00 PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 5.317 | |
| GINKGO BIOWORKS HLDS ERN OUT SHS 700 PP | Ginkgo Bioworks Holdings Earn Out Shares $17.50 PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 5.317 | |
| AFFINIVAX NEXT GEN PROD MILESTON EVNT PP | AFFINIVAX NEXT GEN PROD MILESTON EVNT PP | EC | TC7BEY6E7 | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 7.349.672 |
| Saluda Med Common WTS 3/26 PP | SALUDA MEDICAL WTS COMMON STOCK | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 2 | |
| AFFINIVAX AFX3772 MILESTONE EVENT PP | AFFINIVAX AFX3772 MILESTONE EVENT PP | EC | TC2HD0ET2 | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 7.349.672 |
| GENERATION BIO CO | GENERATION BIO CO | EC | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 102.601 | ||
| GINKGO BIOWORKS HLDS ERN OUT SH 800 PP | Ginkgo Bioworks Holdings Earn Out Shares $20.00 PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 5.317 | |
| EXACT SCIENCES CMO MILESTONE PP | - EXACT SCIENCES CMO MILESTONE PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 3.726.272 | |
| EXACT SCIENCES FDA MILESTONE PP | EXACT SCIENCES FDA MILESTONE PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 1.863.136 | |
| RING THERAPEUTICS INC PP | RING THERAPEUTICS INC PP | EC | TC4CR9CB8 | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 291.704 |
| Medici Tx Platform $3 mil Milestone PP | Medici Tx Platform $3 mil Milestone PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 127.800 | |
| Mirum Pharma Milestone $500 mil PP | Mirum Pharma Milestone $500 mil PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 3.428.195 | |
| Mirum Pharma Milestone $750 mil PP | Mirum Pharma Milestone $750 mil PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 5.713.658 | |
| GYROSCOPE THERAPEUTICS MLSTNE PYMT 1 PP | GYROSCOPE THERAPEUTICS MILESTONE PAYMENT 1 PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 5.683.928 | |
| GYROSCOPE THERAPEUTICS MLSTNE PYMT 2 PP | GYROSCOPE THERAPEUTICS MILESTONE PAYMENT 2 PP | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 3.788.007 | |
| Gesamt | 11.888.028.377 $ | 99,51 | 379.590.382 |